Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...

We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the ...

China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

Organon & Co (OGN) reported its financial results for the fourth quarter of 2024, revealing stable revenue figures in line with forecasts and a slight miss on earnings per share (EPS). Despite this, ...

Radiation Shield Technologies (RST) proudly announces that its groundbreaking anti-radiation fabric, Demron, has been chosen as a critical component in the design of the Mars Spacesuit. Highlighted in ...

Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...

TORONTO and HAIFA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF ... Exo-Top will be positioned to supply high-quality exosomes to other pharmaceutical ...